Summary
This report provides an in-depth understanding of clinical trials in India. While front-end sections such as Executive Summary and Highlights provide the essence of the report in a few pages, the remaining part of the report provides an exhaustive analysis of clinical trails in India. The middle of the report focuses on market scenario and major players. It also comprises an in-depth analysis of the growth prospects of the industry.
The report also covers issues such as technology, growth factors and critical success factors. The regulatory framework, under which the trials are conducted, is discussed briefly. The report also comprises a separate section on the issues and challenges confronting CRO's. The end section of the report contains an outlook for clinical trails in India besides utilities such as glossary. In the outlook section, the report builds upon the information and analysis of the previous chapters to forecast future trends. Life Sciences companies and the companies, which provide services to life sciences companies, will find this report useful.
This report provides a deep understanding of clinical trials in India. Clinical research Organizations (CROs) in India, which are already engaged in clinical trials, will find this report useful in putting their performance in perspective and fine-tuning their strategies as well. For companies planning to enter the clinical trails segment, this report will provide an overview of the current situation and issues that may crop up in the latter part of the trials. Bioservices, which is the fast-growing segment in the industry, is also covered in the report. This report will be useful to companies engaged in biotech services. It will also help Doctors (Investigators), the sponsors of trials and drug companies. Students, who plan to get into clinical trials, will certainly benefit from this report. The drug companies may use this report as a ready reckoner and a source of latest information.
|
